Role of cytochrome P450 2C8 in drug metabolism and interactions

JT Backman, AM Filppula, M Niemi… - Pharmacological reviews, 2016 - ASPET
During the last 10-15 years, cytochrome P450 (CYP) 2C8 has emerged as an important drug-
metabolizing enzyme. CYP2C8 is highly expressed in human liver and is known to …

[HTML][HTML] Drug–drug interaction studies: regulatory guidance and an industry perspective

T Prueksaritanont, X Chu, C Gibson, D Cui, KL Yee… - The AAPS journal, 2013 - Springer
Recently, the US Food and Drug Administration and European Medicines Agency have
issued new guidance for industry on drug interaction studies, which outline comprehensive …

[HTML][HTML] Computational prediction of drug-drug interactions based on drugs functional similarities

R Ferdousi, R Safdari, Y Omidi - Journal of biomedical informatics, 2017 - Elsevier
Therapeutic activities of drugs are often influenced by co-administration of drugs that may
cause inevitable drug-drug interactions (DDIs) and inadvertent side effects. Prediction and …

Coproporphyrins in plasma and urine can be appropriate clinical biomarkers to recapitulate drug-drug interactions mediated by organic anion transporting polypeptide …

Y Lai, S Mandlekar, H Shen, VK Holenarsipur… - … of Pharmacology and …, 2016 - ASPET
In the present study, an open-label, three-treatment, three-period clinical study of
rosuvastatin (RSV) and rifampicin (RIF) when administered alone and in combination was …

Understanding the critical disposition pathways of statins to assess drug–drug interaction risk during drug development: it's not just about OATP1B1

R Elsby, C Hilgendorf, K Fenner - Clinical Pharmacology & …, 2012 - Wiley Online Library
The use of statins is widespread across disease areas because many patients have
comorbidities. Given that these drugs have become common as comedications, it is …

[HTML][HTML] How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion

DB Kell, SG Oliver - Frontiers in pharmacology, 2014 - frontiersin.org
One approach to experimental science involves creating hypotheses, then testing them by
varying one or more independent variables, and assessing the effects of this variation on the …

Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions

S Izumi, Y Nozaki, K Maeda, T Komori… - Drug Metabolism and …, 2015 - ASPET
The risk assessment of organic anion transporting polypeptide (OATP) 1B1–mediated drug-
drug interactions (DDIs) is an indispensable part of drug development. We previously …

Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A

T Prueksaritanont, DA Tatosian, X Chu… - Clinical …, 2017 - Wiley Online Library
A microdose cocktail containing midazolam, dabigatran etexilate, pitavastatin, rosuvastatin,
and atorvastatin has been established to allow simultaneous assessment of a perpetrator …

Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide 1B clinical probe than rosuvastatin

T Prueksaritanont, X Chu, R Evers… - British journal of …, 2014 - Wiley Online Library
Aims Rosuvastatin and pitavastatin have been proposed as probe substrates for the organic
anion‐transporting polypeptide (OATP) 1 B, but clinical data on their relative sensitivity and …

[HTML][HTML] Regulation of organic anion transporting polypeptides (OATP) 1B1-and OATP1B3-mediated transport: an updated review in the context of OATP-mediated …

K Alam, A Crowe, X Wang, P Zhang, K Ding… - International journal of …, 2018 - mdpi.com
Organic anion transporting polypeptides (OATP) 1B1 and OATP1B3 are important hepatic
transporters that mediate the uptake of many clinically important drugs, including statins from …